IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
542.71
+0.06 (0.01%)
Jul 2, 2025, 4:00 PM - Market closed
IDEXX Laboratories Stock Forecast
Stock Price Forecast
The 8 analysts that cover IDEXX Laboratories stock have a consensus rating of "Buy" and an average price target of $542.25, which forecasts a -0.08% decrease in the stock price over the next year. The lowest target is $475 and the highest is $580.
Price Target: $542.25 (-0.08%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for IDEXX Laboratories stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 4 | 4 | 4 | 4 | 4 | 4 |
Hold | 3 | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Stifel | Stifel | Hold Maintains $510 → $540 | Hold | Maintains | $510 → $540 | -0.50% | Jul 2, 2025 |
Leerink Partners | Leerink Partners | Buy Maintains $515 → $580 | Buy | Maintains | $515 → $580 | +6.87% | Jun 11, 2025 |
Stifel | Stifel | Hold Maintains $460 → $510 | Hold | Maintains | $460 → $510 | -6.03% | May 19, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $548 → $558 | Buy | Maintains | $548 → $558 | +2.82% | May 5, 2025 |
B of A Securities | B of A Securities | Hold Maintains $535 → $475 | Hold | Maintains | $535 → $475 | -12.48% | Apr 21, 2025 |
Financial Forecast
Revenue This Year
4.22B
from 3.90B
Increased by 8.27%
Revenue Next Year
4.55B
from 4.22B
Increased by 7.73%
EPS This Year
12.41
from 10.67
Increased by 16.27%
EPS Next Year
13.92
from 12.41
Increased by 12.22%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 4.4B | 4.7B | 5.1B | ||
Avg | 4.2B | 4.5B | 4.9B | ||
Low | 4.0B | 4.3B | 4.6B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 12.5% | 12.1% | 12.7% | ||
Avg | 8.3% | 7.7% | 8.3% | ||
Low | 3.3% | 2.2% | 1.6% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 13.04 | 14.63 | 16.65 | ||
Avg | 12.41 | 13.92 | 15.67 | ||
Low | 11.62 | 12.92 | 13.98 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 22.2% | 18.0% | 19.6% | ||
Avg | 16.3% | 12.2% | 12.5% | ||
Low | 8.9% | 4.1% | 0.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.